Clicky

Humanigen, Inc.(HGEN) News

HGEN price today by TradingView
Date Title
Aug 7 Humanigen Announces First Participant Dosed in RATinG Trial of Lenzilumab for Early Treatment of Acute Graft Versus Host Disease Following Allogeneic Stem Cell Transplantation